GB9221468D0 - Pharmaceuticals - Google Patents

Pharmaceuticals

Info

Publication number
GB9221468D0
GB9221468D0 GB929221468A GB9221468A GB9221468D0 GB 9221468 D0 GB9221468 D0 GB 9221468D0 GB 929221468 A GB929221468 A GB 929221468A GB 9221468 A GB9221468 A GB 9221468A GB 9221468 D0 GB9221468 D0 GB 9221468D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceuticals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB929221468A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GB929221468A priority Critical patent/GB9221468D0/en
Publication of GB9221468D0 publication Critical patent/GB9221468D0/en
Priority to MX9306310A priority patent/MX9306310A/en
Priority to ZA937505A priority patent/ZA937505B/en
Priority to EP93922942A priority patent/EP0664808A1/en
Priority to AU51770/93A priority patent/AU5177093A/en
Priority to JP6509615A priority patent/JPH08502274A/en
Priority to CN93114853A priority patent/CN1092775A/en
Priority to PCT/EP1993/002808 priority patent/WO1994008998A1/en
Priority to CA002146928A priority patent/CA2146928A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
GB929221468A 1992-10-13 1992-10-13 Pharmaceuticals Pending GB9221468D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GB929221468A GB9221468D0 (en) 1992-10-13 1992-10-13 Pharmaceuticals
MX9306310A MX9306310A (en) 1992-10-13 1993-10-11 ANTAGONIST COMPOUNDS OF THE 5-HT4 RECEPTOR, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
ZA937505A ZA937505B (en) 1992-10-13 1993-10-11 Imidazopyridine derivatives as 5-HT4 receptor antagonists
EP93922942A EP0664808A1 (en) 1992-10-13 1993-10-12 Imidazopyridine derivatives as 5-ht 4? receptor antagonists
AU51770/93A AU5177093A (en) 1992-10-13 1993-10-12 Imidazopyridine derivatives as 5-ht4 receptor antagonists
JP6509615A JPH08502274A (en) 1992-10-13 1993-10-12 5-HT 4) Imidazopyridine derivative for receptor antagonist
CN93114853A CN1092775A (en) 1992-10-13 1993-10-12 Medicine
PCT/EP1993/002808 WO1994008998A1 (en) 1992-10-13 1993-10-12 Imidazopyridine derivatives as 5-ht4 receptor antagonists
CA002146928A CA2146928A1 (en) 1992-10-13 1993-10-12 Imidazopyridine derivatives as 5-ht4 receptor antagonists

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929221468A GB9221468D0 (en) 1992-10-13 1992-10-13 Pharmaceuticals

Publications (1)

Publication Number Publication Date
GB9221468D0 true GB9221468D0 (en) 1992-11-25

Family

ID=10723359

Family Applications (1)

Application Number Title Priority Date Filing Date
GB929221468A Pending GB9221468D0 (en) 1992-10-13 1992-10-13 Pharmaceuticals

Country Status (9)

Country Link
EP (1) EP0664808A1 (en)
JP (1) JPH08502274A (en)
CN (1) CN1092775A (en)
AU (1) AU5177093A (en)
CA (1) CA2146928A1 (en)
GB (1) GB9221468D0 (en)
MX (1) MX9306310A (en)
WO (1) WO1994008998A1 (en)
ZA (1) ZA937505B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5998409A (en) * 1992-03-12 1999-12-07 Smithkline Beecham Plc Condensed indole derivatives as 5HT4 -receptor antagonists
US5852014A (en) * 1992-03-12 1998-12-22 Smithkline Beecham P.L.C. Condensed indole derivatives as 5HT4 -receptor antagonists
EP0664794A1 (en) * 1992-10-16 1995-08-02 Smithkline Beecham Plc N-alkylpiperidinyl-4-methyl carboxylic esters/amides of condensed ring systems as 5-ht4 receptor antagonists
KR100469029B1 (en) * 1996-02-15 2005-05-27 얀센 파마슈티카 엔.브이. Use of 5HT4 Receptor Antagonists to Overcome the Gastrointestinal Effects of Serotonin Reuptake Inhibitors
FR2797630B1 (en) * 1999-08-20 2005-04-29 Univ Caen Basse Normandie PYRROLO [1,2-a] QUINOXALINE ETHER DERIVATIVES, PROCESS FOR PREPARING THEM AND THEIR THERAPEUTIC APPLICATION
EP1440071B1 (en) * 2001-10-22 2005-10-26 Pfizer Inc. Imidazopyridine compounds as 5-ht 4? receptor modulators
US6624162B2 (en) 2001-10-22 2003-09-23 Pfizer Inc. Imidazopyridine compounds as 5-HT4 receptor modulators
MXPA03000145A (en) 2002-01-07 2003-07-15 Pfizer Oxo or oxy-pyridine compounds as 5-ht4 receptor modulators.
GB0211230D0 (en) 2002-05-16 2002-06-26 Medinnova Sf Treatment of heart failure
AU2003259482A1 (en) * 2002-09-20 2004-04-08 Pfizer Japan Inc. N-substituted piperidinyl-imidazopyridine compounds as 5-ht4 receptor modulators
DOP2003000703A (en) * 2002-09-20 2004-03-31 Pfizer IMIDAZOPIRADINE COMPOUNDS AS 5-HT4 RECEIVER AGONISTS
BRPI0409592A (en) * 2003-04-21 2006-05-02 Pfizer imidazopyridine compounds having 5-ht4 receptor agonistic activity and 5-ht3 receptor antagonistic activity
EP1758891A2 (en) 2004-06-15 2007-03-07 Pfizer Japan Inc. Benzimidazolone carboxylic acid derivatives
US7737163B2 (en) 2004-06-15 2010-06-15 Pfizer Inc. Benzimidazolone carboxylic acid derivatives
CN104761551A (en) * 2015-03-31 2015-07-08 山东友帮生化科技有限公司 Method for synthesizing 6-iodo-8-carboxylimidazo(1,2-a)pyridine
CN104725376A (en) * 2015-03-31 2015-06-24 山东友帮生化科技有限公司 Synthetic method of 6-chlorine-8-carboxyl imidazo [1,2-a] pyridine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9103862D0 (en) * 1991-02-25 1991-04-10 Glaxo Group Ltd Chemical compounds
US5260303A (en) * 1991-03-07 1993-11-09 G. D. Searle & Co. Imidazopyridines as serotonergic 5-HT3 antagonists

Also Published As

Publication number Publication date
MX9306310A (en) 1994-04-29
EP0664808A1 (en) 1995-08-02
CA2146928A1 (en) 1994-04-28
CN1092775A (en) 1994-09-28
ZA937505B (en) 1994-07-22
WO1994008998A1 (en) 1994-04-28
AU5177093A (en) 1994-05-09
JPH08502274A (en) 1996-03-12

Similar Documents

Publication Publication Date Title
AP9300494A0 (en) Pharmaceuticals
GB9221468D0 (en) Pharmaceuticals
GB9204565D0 (en) Pharmaceuticals
GB9219163D0 (en) Pharmaceuticals
GB9214184D0 (en) Pharmaceuticals
GB9205917D0 (en) Pharmaceuticals
GB9201961D0 (en) Pharmaceuticals
GB9220585D0 (en) Pharmaceuticals
GB9208321D0 (en) Pharmaceuticals
GB9211926D0 (en) Pharmaceuticals
GB9216906D0 (en) Pharmaceuticals
GB9205365D0 (en) Pharmaceuticals
GB9205427D0 (en) Pharmaceuticals
GB9205428D0 (en) Pharmaceuticals
GB9203977D0 (en) Pharmaceuticals
GB9205918D0 (en) Pharmaceuticals
GB9206075D0 (en) Pharmaceuticals
GB9207414D0 (en) Pharmaceuticals
GB9207820D0 (en) Pharmaceuticals
GB9202510D0 (en) Pharmaceuticals
GB9208434D0 (en) Pharmaceuticals
GB9211072D0 (en) Pharmaceuticals
GB9211082D0 (en) Pharmaceuticals
GB9211925D0 (en) Pharmaceuticals
GB9201946D0 (en) Pharmaceuticals